| Q26752904 | A Common Language: How Neuroimmunological Cross Talk Regulates Adult Hippocampal Neurogenesis |
| Q34017893 | A novel conditional genetic system reveals that increasing neuronal cAMP enhances memory and retrieval. |
| Q27026440 | Acute and chronic stress-induced disturbances of microglial plasticity, phenotype and function |
| Q38868897 | Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation |
| Q27324133 | Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA? |
| Q49335692 | Aripiprazole exerts a neuroprotective effect in mouse focal cerebral ischemia |
| Q92352855 | Augmented β2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size |
| Q33861951 | Brain renin-angiotensin system and dopaminergic cell vulnerability |
| Q43187968 | C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. |
| Q38182045 | Calcium ion influx in microglial cells: physiological and therapeutic significance |
| Q36369800 | Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. |
| Q43164978 | Charge compensation for NADPH oxidase activity in microglia in rat brain slices does not involve a proton current. |
| Q45992958 | Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms. |
| Q39041839 | DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline |
| Q36254342 | De novo expression of dopamine D2 receptors on microglia after stroke |
| Q26772830 | Depression as a Glial-Based Synaptic Dysfunction |
| Q58750811 | Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine |
| Q37617452 | Dopamine D1 Receptor Immunoreactivity on Fine Processes of GFAP-Positive Astrocytes in the Substantia Nigra Pars Reticulata of Adult Mouse. |
| Q38868116 | Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons |
| Q38366498 | Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases |
| Q27316037 | Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis |
| Q91763700 | Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation |
| Q38127396 | Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. |
| Q39348712 | Dopaminergic Regulation of Innate Immunity: a Review. |
| Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
| Q34049955 | FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration |
| Q35162073 | Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity |
| Q36606095 | Functional role of calcium signals for microglial function. |
| Q46220425 | GABAergic activities enhance macrophage inflammatory protein-1alpha release from microglia (brain macrophages) in postnatal mouse brain. |
| Q28307030 | Glial modulators as potential treatments of psychostimulant abuse |
| Q88588848 | HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific |
| Q35009465 | HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse |
| Q97643549 | Hypothalamic microglia as potential regulators of metabolic physiology |
| Q38148183 | Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity |
| Q36593579 | Increased MCP-1 and microglia in various regions of the human alcoholic brain |
| Q33602755 | Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling |
| Q35007339 | Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors |
| Q38222226 | Macrophage subsets and microglia in multiple sclerosis |
| Q38969930 | Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration. |
| Q37395333 | Microfluidics: a new cosset for neurobiology |
| Q26742077 | Microglia Ontology and Signaling |
| Q90564251 | Microglia Receptors in Animal Models of Traumatic Brain Injury |
| Q37080038 | Microglia during development and aging |
| Q41699494 | Microglia: An Interface between the Loss of Neuroplasticity and Depression |
| Q36654256 | Microglial control of neuronal death and synaptic properties |
| Q58610287 | Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamine |
| Q37389383 | Microglial responses to dopamine in a cell culture model of Parkinson's disease. |
| Q34613996 | Mollaret meningitis may be caused by reactivation of latent cerebral toxoplasmosis |
| Q21558407 | Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone |
| Q35003502 | Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum. |
| Q27027973 | Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity |
| Q92228635 | Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-γ-dependent manner |
| Q37136971 | Neuronal influence behind the central nervous system regulation of the immune cells. |
| Q41678707 | Neurotransmitter receptors on microglia |
| Q41864750 | Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. |
| Q30540053 | Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors |
| Q39660802 | Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. |
| Q36326881 | Oxidative and nitrative stress in neurodegeneration |
| Q42511699 | Presence of D1- and D2-like dopamine receptors in the rat, mouse and bovine multiciliated ependyma. |
| Q36387362 | Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders |
| Q51420440 | Purine Signaling and Microglial Wrapping. |
| Q80866653 | Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS |
| Q38505120 | Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells |
| Q90294828 | Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders |
| Q36426971 | Role of nonsynaptic communication in regulating the immune response. |
| Q52141287 | Satellite microglia show spontaneous electrical activity that is uncorrelated with activity of the attached neuron. |
| Q91972968 | The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia |
| Q35116966 | The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III |
| Q35294476 | The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q52649972 | The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. |
| Q22252519 | The immunoregulatory role of dopamine: an update |
| Q34024675 | The myeloid cells of the central nervous system parenchyma |
| Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
| Q55035979 | The role of dopaminergic immune cell signalling in poststroke inflammation. |
| Q57476258 | The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD |
| Q87248985 | The subpopulation of microglia sensitive to neurotransmitters/neurohormones is modulated by stimulation with LPS, interferon-γ, and IL-4 |
| Q34537105 | Transiently increasing cAMP levels selectively in hippocampal excitatory neurons during sleep deprivation prevents memory deficits caused by sleep loss |
| Q35762278 | Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia |
| Q98213535 | Understanding Microglial Diversity and Implications for Neuronal Function in Health and Disease |
| Q38430656 | Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets. |
| Q39012371 | l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? |